Skip to main content
Premium Trial:

Request an Annual Quote

I3C from A to Z: Total Participants as of June 2001

Premium
Accelrys Incyte
Accenture Ingenuity
Affymetrix LabBook
Allegro Bioscience Micromass
AP Biotech Millennium Pharmaceuticals
Apple National Cancer Institute
Automated Cell Object Management Group, Lifescience Research Task Force chairs
Beyond Genomics Open-bio
Biotechnology Industry Organization Oracle
Bio-ontologies and Bio-pathways PharmQuest
Blackstone Technology Group Physiome Sciences
Caprion Pharmaceuticals SAS
CGI (Conseillers et Gastion et Informatique) Silicon Genetics
DNA Landmarks/BASF SRA International
DoubleTwist Sun Microsystems
European Bioinformatics Institute Surromed
Functional Genetics TimeLogic
Gene Data TurboGenomics
Gene Logic United States Patent &Trademark Office
GeneticXchange University of Manchester
Genomica Virginia Biotech Institute
Hybrigenics Whitehead Institute
IBM Zerosum
Incogen  

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.